Medical Oncology Grand Rounds


Grand Rounds begin each year in September after completion of the introductory lecture series. Fellows and faculty members give 30- to 60-minute, case-based discussions and literature reviews on subjects of their choosing.


Friday, Noon-1:00 PM, Holden Auditorium (unless otherwise noted)

2016-2017 Academic Year

Date Speaker Title  
Jul 15, 2016
14th Fl NW Tower
Doug Adkins Introduction to Cancer Management
Writing Chemo Orders: The Basics I Must Know and Implement
Jul 22, 2016
14th Fl NW Tower
Janelle Mann
Staff Pharmacist, Medical Oncology
Introduction to Cancer Management
The Ins and Outs of Anti-Emetics
Jul 29, 2016
14th Fl NW Tower
Cynthia Ma Introduction to Cancer Management
Metastatic Hormone Positive Breast Cancer
Aug 5, 2016
14th Fl NW Tower
Daniel Morgensztern Introduction to Cancer Management
Non-Small Cell Lung Cancer
Aug 12, 2016
14th Fl NW Tower
Tanya Wildes Introduction to Cancer Management
Head and Neck Cancer
Aug 19, 2016 William D. Tap, MD
Memorial Sloan Kettering Cancer Center, New York, NY
The Pit and the Pendulum, Emerging Therapies in Soft Tissue Sarcoma
Aug 26, 2016
Cori Auditorium
Nancy Bartlett Introduction to Cancer Management
Hodgkin Lymphoma
Sep 2, 2016 Nancy Bartlett Targeted Approaches to Diffuse Large B Cell Lymphoma
Sep 9, 2016
Cori Auditorium
Timothy Ley Acute Myeloid Leukemia
Sep 16, 2016 Todd Fehniger Natural Killer Cell Immunotherapy: Prime or Recollect?
Sep 23, 2016
EPNEC Seminar Room B
Gloria M. Petersen, PhD
Mayo Clinic College of Medicine, Rochester, MN
Lori Groetken Memorial Lecture
Genetic Susceptibility to Pancreatic Cancer: New Insights
Sep 30, 2016 Todd Druley
Pediatric Hematology/Oncology
Leukemia-associated Clonal Hematopoiesis Is a Ubiquitous Process in Normal Aging
Oct 7, 2016 Cynthia Ma CDK 4/6 in ER+ Breast Cancer
Oct 14, 2016 Lingling Du
Hematology-Oncology Fellow
IDO Inhibition in Cancer Treatment
Oct 21, 2016 Gideon M. Blumenthal, MD
Center for Drug Evaluation and Research, FDA, Bethesda, MD
Clinical Trials and Drug Development in Oncology: FDA's Perspective
Oct 28, 2016 Katherine Weilbaecher Targeting Dormant and Growing Bone Metastases
Nov 4, 2016 Craig Lockhart Strategic Targeting of Esophageal Cancers: 2016 Update
Nov 11, 2016 Bita Fakhri
Hematology-Oncology Fellow
Livin' on a Prayer: Double and Triple Hit Lymphomas
  Amber Xu
Hematology-Oncology Fellow
Paraneoplastic Opsoclonus-Myoclonus Syndrome
Nov 18, 2016 Sana Saif Ur Rehman
Hematology-Oncology Fellow
Chronic Neutrophilic Leukemia: Novel Mutations and Impact on Clinical Practice
Dec 9, 2016 Tom Regenbogen
Hematology-Oncology Fellow
Non-Surgical Liver Directed Therapy
Dec 16, 2016 Mark Watson
Laboratory & Genomic Medicine
Detection of Rare Tumor Cells
Jan 6, 2017 Scott Kopetz, MD, PhD
MD Anderson Cancer Center, Houston, TX
Targeting BRAF in Colorectal Cancer
Jan 20, 2017 Francesca Ferraro
Hematology-Oncology Fellow
Hypomethylating Agents in Acute Myeloid Leukemia
  Eric Huselton
Hematology-Oncology Fellow
BCL-2 Inhibition in CLL
Jan 27, 2017 Marcel van den Brink, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY
Strategies to Enhance Hematopoietic Stem Cell Transplantation
Feb 3, 2017 Sid Devarakonda
Hematology-Oncology Fellow
Origins and Genomic Landscape of Small Cell Lung Cancer
Feb 10, 2017 Sam Achilefu
Light Mediated Molecular Imaging and Treatment of Cancer
Feb 17, 2017
Cori Auditorium
Maria-Grazia Roncarolo, MD
Stanford University, Stanford, CA
T Regulatory Cells in Immunomediated Diseases: From Bench to Bedside and Beyond
Feb 24, 2017 Richard Wahl
Quantitative Imaging to Phenotype Patients With Cancer
Mar 3, 2017 Deborah Schrag, MD, MPH
Dana-Farber Cancer Institute, Boston, MA
Pilots to Populations: Quality, Efficacy and Effectiveness of Rectal Cancer Treatment
Mar 10, 2017
Cori Auditorium
Andy Liao
Hematology-Oncology Fellow
Emerging Treatment Options in Cholangiocarcinoma
Mar 17, 2017 Amanda Cashen CAR T-Cells: How Will We Weigh the Risks and Benefits?
Mar 24, 2017
Cori Auditorium
Ezra Cohen, MD
UC San Diego, La Jolla, CA
Immune Approaches in Head and Neck Cancer
Mar 31, 2017 Natasha Edwin
Hematology-Oncology Fellow
Burnout Among Oncologists
  Patrick Grierson
Hematology-Oncology Fellow
Immunotherapy in GI Malignancies
Apr 7, 2017 Aabha Oza
Hematology-Oncology Fellow
Peritoneal Carcinomatosis: Intraperitoneal Chemotherapy and Cytoreductive Surgery
  Stephen Barman
Hematology-Oncology Fellow
Urothelial Carcinoma: Review and Updates of Second-Line Treatment
Apr 14, 2017
Cori Auditorium
Goutham Narla
Case Western Reserve University, Cleveland, OH
Novel Therapies to Activate Tumor Suppressor Proteins for Cancer Treatment
Apr 21, 2017 Kwok-Kin Wong, MD, PhD
NYU Langone Medical Center, New York, NY
The Use of Mouse Lung Cancer Models for Preclinical Testing of Novel Targeted and Immune Therapies
Apr 28, 2017 Vassiliki Saloura
University of Chicago
WHSC1L1 as an Oncogenic Methyltransferase in Head and Neck Cancer: Progress Towards Clinical Translation
May 5, 2017 Tanya Wildes Age Is Just a Surrogate for Aging: Weaving the Principals of Geriatrics Into the Fabric of Oncology
May 12, 2017
Erlanger Auditorium
Tanner Johanns
Hematology-Oncology Fellow
May 19, 2017
Erlanger Auditorium
Nusayba Bagegni
Hematology-Oncology Fellow
  Francesca Ferraro
Hematology-Oncology Fellow
May 26, 2017 Nkiruka Ezenwajiaku
Hematology-Oncology Fellow
  Amber Afzal
Hematology-Oncology Fellow
Jun 2, 2017 No Conference - ASCO meeting
Jun 9, 2017 Patrick Grierson
Hematology-Oncology Fellow
  Pavan Bhamidipati
Hematology-Oncology Fellow
Jun 16, 2017 Chris Maher
Jun 23, 2017 Matt Walter
Jun 30, 2017 F. Stephen Hodi, MD
Dana-Farber Cancer Institute, Boston, MA